Biblioteca Humberto Rosselli Quijano
Volver a la pantalla de resultados de la última búsqueda | Consultar el historial de búsquedas | New search |
Resultado de la búsqueda
1 búsqueda de la palabra clave 'Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette.'
Refinar búsqueda Générer le flux rss de la recherche
Lien permanent de la recherche
Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial / Yves Dion en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Febrero)
[artículo]
Título : Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial Tipo de documento: texto impreso Autores: Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor Fecha de publicación: 2023 Artículo en la página: pp. 31-39 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39[artículo] Risperidone in the treatment of tourette syndrome: a double-blind, placebo-controlled trial [texto impreso] / Yves Dion, Autor ; Lawrence Annable, Autor ; Paul Sandor, Autor . - 2023 . - pp. 31-39.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Febrero) . - pp. 31-39
Palabras clave: Discinesia inducida por fármacos, Examen neurológico, Risperidona, Síndrome de Tourette. Resumen: A double-blind, placebo-controlled trial was performed to determine the efficacy and tolerability of 8 weeks of treatment with risperidone in the management of 48 adolescent and adult patients with Tourette syndrome. Twenty-four patients were randomly assigned to treatment with risperidone in doses of 0.5 to 6.0 mg/day, and 24 were assigned to placebo. Link: ./index.php?lvl=notice_display&id=31091